Kings College London [KCL] has received over £800,000 from Janssen for Esketamine research.
Professor Allan Young, Vice Dean and Clinical Academic Lead for KCL, features in this Guardian “Exclusive” [from last Friday 12 November 2021] . Professor Young is lobbying for Esketamine to be approved by NICE . His financial ties to its maker Janssen have not been declared.
This short excerpt from the 52nd Maudsley debate, is now 7 years old:
Transparency and British Psychiatry: Hold the applause
[please click on the image below to play this short film – the film is less than 3 minutes long and also includes considerations on declarations of competing interests by Professor Allan Young]